I wouldn't claim to know any more about what's going to

New Post Public Reply Private Reply Replies (7) Message Board
Respert24
1,451
I wouldn't claim to know any more about what's going to happen on Wednesday's call than anyone else. I bought in around February of 2019 and have continued to increase my shares with the exception of a small amount I sold to cover the cost of some home renovations. I'm up a good bit. Even after the great bull*$#& collapse from $10 to $3-ish, because I'm an expert investor*.

*Not true about being an expert, just lucky I think

So what do I think is going to happen on the call Wednesday? Great question and thank you so much for asking me...

Details of the current discussions with MHRA in regards to fast track approval for COVID-19

Would it be written that way if the MHRA had already told us to bugger off?

(Please award me appropriate points for using "bugger", which I'm only 85% sure is a term used in the UK. Bollocks if not.)

I still think this is the best possible route to revenue at this moment. They developed NEWS2 and we crushed it. They also have a good bit of Covid still. I'm no mathematishionist* but that adds up to a win in my book. I'll also wager that they're at least a little less corrupt than the FDA and can see a f*$&ing gift horse when it presents itself. Also don't sleep in Israel. They wouldn't normally be in the top 5 of countries approached so there are reasons and relationships driving that which can make all the difference.

*Medical term

Status of Emergency Use Approval for COVID-19, CD10 trial in U.S.

I believe this portion of the call will go like this:

NP: The FDA has been amazing so far and they have asked us for some data around the trial that we are providing by sometime next week. After we submit that data we expect feedback within 1-2 weeks and we are thankful for the (corrupt and pathetic*) FDA's efforts in helping bring this important product to market. Can-kicking down the road in other words.

*My words, but I think we an all agree that there's some shenanigans occurring right now within the FDA

Detail discussions of the cancer results and discussions from invited guest (from Creative MicroTech) on the leronlimab potential in all cancers based on current results in the last 1 year

This is actually pretty exciting. Aren't we awaiting a breakthrough designation on the basket cancers? They, meaning Creative MicroTech, have apparently been involved for a little while now and if patients are continuing to end up with 0 circulating tumor cells than watch out!

HIV – BLA submission in U.S. and U.K.

Spoiler alert because Cytodyn wants it and they've asked for it and they've not been responded to yet. At least in the US. Try to keep it in your pants as we don't get any substantial news on this front from the states. But maybe we get a nugget or two from the UK. I mean, for crying out loud the evidence is substantial at this point. We just need someone who isn't "conflicted" to look at it.

HIV – cure project

How great would it be if they've already injected a few patients?! I know this kind of trial depends on when they're scheduled for their transplant but I have to imagine this makes all the news sites if it's successful so I'm anxious to see it get underway.

NASH timeline

I think they're finally ready to start really sinking money into this. Sucks that a fully funded, revenue generating company would have probably been further along but we aren't here to turn a $79/share stock into $94. We're trying to usher this "penny" OTC stock into the stratosphere for a much greater return. Dem's the breaks.

Potential other trials

Clearly it's not anything of substance if we're just talking "potential". I'd love an MS or Alzheimer's trial as much as the next guy but I'm banking on the fact that these sorts of things are too fringe to be happening any time soon.

Scientific Advisory Board

Wait! We have a science board?! I had no idea!!!

Kidding, of course. This is a tremendous idea that will pay off significantly over time. I can't imagine there's any meat on this bone right now though,as they just started announcing people. I'm guessing we just added another one or two people at this point.

NASDAQ uplist

People really have their you know what's in a wad over this. Nasdaq folks appear to be behind their traditional timelines right now. But even then they explain publicly that the time for the company to respond to questions is a 1-2 week process and the time that NASDAQ takes to process that information is another 1-2 weeks. So we are well within that timeframe and looking at another week or so before we can reasonably expect an answer without any other variables getting involved.

But here's the thing. We qualify. There's no reason we shouldn't be accepted. Same for HIV BLA. We qualify. There's no real reason we shouldn't be accepted.

When it comes to Covid I'm as annoyed as the rest of you about exposure but consider that almost nobody posting about Covid treatments is really an expert about what's going on. If you start googling monoclonal antibodies you will find a lot of information about everything but Leronlimab. Hell, even stat news has an article on the first page because they understand how to abuse the system and show up in searches. People who do the laziest of DD will not easily find Cytodyn or learn much of substance about Leronlimab. It perpetuates itself.

The MINUTE we get an authorization in another country (which is my prediction for how it will go, by the way) we will be contracting with them to sell over 1 BILLION DOLLARS in inventory. That's all we need. The media will follow. The share price will rise. The approvals will follow. The share price will rise. The reserving/purchase of 2021's stock will happen and that will be far more than 1 Billion dollars. The share price will rise. The agreements to increase production will happen. Me spending an absurd amount of money on a bottle of wine to celebrate will happen. Gloating to AF on twitter and calling him a failed Dbag will happen. You get the point. I'll be drunk and pretending like I knew all along exactly how it would go while conveniently forgetting that I predicted we'd be at $20+ weeks ago.

Long. Strong. And about to get the friction on.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CPC's Rigorous Self-Governance Balances Power Effectively

Updated Category News Views 212

What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...

Continue Reading
SICO Snags $1.6B in New Investor Mandates for 2026

Updated Category News Views 110

SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...

Continue Reading
Ensuring Flooring Stability: Acclimation's Key Role

Updated Category News Views 191

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Continue Reading
Orthocell's Remplir™ Hits Record U.S. Sales in October

Updated Category News Views 51

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Continue Reading
Naviu's AI Travel Guide: Revolutionizing Japan Tours

Updated Category News Views 306

A New Era of Touring Japan: Meet Naviu Alright, travelers, strap in—Naviu is about to flip your trip to Japan upside down. Launching November 1st, 2026, this AI-powered augmented reality travel companion is trying to make exploring Japan easier than ever. Behind this innovative gem is TANGLE Inc., working with technology so cutting-edge, it's practically slicing through...

Continue Reading
Knob-and-Tube Wiring: A Hidden Hazard Unveiled

Updated Category News Views 112

Unlocking the Mysteries of Knob-and-Tube Wiring Ever wondered if the wiring in your charming hundred-year-old home might be a ticking time bomb? Welcome to the world of knob-and-tube wiring. This blast from the past might just be hiding in those walls and could spell trouble. The History and Hazards of Knob-and-Tube This wiring system dates back to the 1880s, sticking...

Continue Reading
Chiropractic Insights: Differentiating Piriformis vs. Disc Pain

Updated Category News Views 143

Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...

Continue Reading
Roof Flashing Insights with Expert Jeremiah Lightsey

Updated Category News Views 287

Why Flashing Is the Backbone of a Leak-Free Roof Ever wonder why some roofs just seem to withstand the wrath of Mother Nature better? The answer, my friends, often boils down to a little unsung hero: roof flashing. Our roof parts aren't exactly playing an even game; you've got chimneys, walls, skylights, just asking for trouble. That's where flashing steps in like an...

Continue Reading
OlloBot's Emotional AI Robots Connect Beyond Tasks

Updated Category News Views 409

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...

Continue Reading
Double Down for Veterans Raises $20 Million Goal

Updated Category News Views 196

Helping Veterans: A Call That Never Fades If there's one thing that never changes, it's the enduring need to support those who have served. Semper Fi & America's Fund has been at the forefront of this mission for over a decade, and their annual Double Down for Veterans Match Campaign is nothing short of a testament to unwavering commitment. Kicking off for the 15th time,...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Bitcoin Treasury Holdings and Market Impacts

Updated Category News Views 180

The Dynamics of Bitcoin and Treasury Companies In recent months, the activity surrounding Bitcoin has captured the financial world's attention, especially with treasury companies increasingly acquiring substantial amounts of BTC. However, despite this significant uptick in investment, the anticipated price escalation has not occurred as expected. Trends in Corporate...

Continue Reading
North Highland's NH360 Recognized for Technological Innovation

Updated Category News Views 146

North Highland's Recognition in Enterprise Architecture Management North Highland has received notable recognition from an independent research firm for its NH360 platform, a powerful tool in the realm of Enterprise Architecture Management (EAM). This acknowledgment highlights the consultancy's ongoing commitment to innovation and comprehensive support for its clients....

Continue Reading
Oragenics, Inc. Set to Share Innovations at Key Summit

Updated Category News Views 40

Oragenics, Inc. Highlights Presentation at Upcoming Summit Oragenics Inc. (NYSE American: OGEN), recognized for its innovative approach towards developing treatments for brain-related health conditions, is gearing up for a significant appearance at a prestigious event. The company will be presenting at the Centurion One Capital 2nd Annual Bahamas Summit located at the...

Continue Reading
Kellanova Share Transactions and Market Developments Explored

Updated Category News Views 93

Kellanova Shares Sold by Kellogg Foundation Trust In a recent move that captured attention, the Kellogg W.K. Foundation Trust sold a significant number of shares in Kellanova, a company well-known for its grain mill products. Specifically, the Trust divested 114,583 shares priced at $80.6845 each, totaling approximately $9,245,072. This kind of transaction highlights the...

Continue Reading
Exploring the Rapid Growth of the Baby Products Industry

Updated Category News Views 408

Understanding the Baby Products Market Surge The baby products market is experiencing remarkable growth, influenced by several factors such as rising birth rates, increased spending on baby care products, and a heightened awareness of infant health. Parents are increasingly seeking organic and toxin-free options, leading to significant changes in purchasing preferences....

Continue Reading